Bio
Kerecis Company Overview Kerecis is a biotechnology company focused on tissue regeneration through the use of sustainably sourced fish skin. Originally developed for human medicine, Kerecis products are now used across a wide range of clinical applications, supporting wound healing in both human and veterinary patients. The company’s core technology is an intact fish skin graft derived from wild Atlantic cod. The material is minimally processed to preserve its natural structure, including a three-dimensional architecture and molecular composition that closely resembles human skin. This allows the graft to function as a biologic scaffold, supporting cellular ingrowth and the body’s natural regenerative processes when applied to damaged tissue. Kerecis grafts are used to manage a broad spectrum of wounds, including acute and chronic wounds, traumatic injuries, surgical wounds, and burns. Clinical application spans from straightforward wound coverage to more complex cases where progression through the healing pathway may be delayed or compromised. In veterinary medicine, Kerecis VET extends this technology across a diverse range of species. The graft is used in small and large animals, as well as in avian, reptile, and aquatic species, supporting tissue repair across acute and chronic, partial and full-thickness wounds, including traumatic injuries and burns. This expanded application reflects both the variability of veterinary wound presentation and the practical need for adaptable treatment strategies in clinical practice. When applied, the graft integrates with the wound bed, enabling recruitment of the patient’s own cells and supporting tissue organization and coverage. This cross-species applicability reflects the conserved structural characteristics of skin across vertebrates and expands the clinical versatility of the product. A defining aspect of the Kerecis technology is its preservation of natural biological properties. Unlike more heavily processed materials, the intact structure of the fish skin provides an environment favorable for cellular ingrowth and vascularization. The material retains natural components, including omega 3 fatty acids, which contribute to its biologic activity and interaction with the wound environment. Kerecis products are manufactured using sustainably sourced fish skin that would otherwise be discarded as a by-product of the fishing industry. The company’s production process emphasizes minimal environmental impact, using renewable energy and responsible sourcing practices to convert this material into medical-grade technology. Headquartered in Iceland, Kerecis operates globally, with regulatory clearances in the United States, Europe, and other international markets. As part of Coloplast, a global leader in medical technology, Kerecis benefits from expanded reach and infrastructure while maintaining its focus on biologic innovation and tissue regeneration.
Chat with us 💬